Smoking affects gut immune system of patients with inflammatory bowel diseases by modulating metabolomic profiles and mucosal microbiota

COMMENTED

Gastrointestinal CancerInflammatory Bowel Disease

Blood-borne immune cells carry low biomass DNA remnants of microbes in patients with colorectal cancer or inflammatory bowel disease

★ 3 Recommended and commented by Prof. Dr Stephan Vavricka, Faculty Member

Gut Microbes

Morsy Y, Walberg Å, Wawrzyniak P, Hubeli B, Truscello L, Mamie C, Niechcial A, Gueguen E, Manzini R, Gottier C, Lang S, Scharl S, Blümel S, Biedermann L, Rogler G, Turina M, Ramser M, Petrowsky H, Arnold IC, Zeissig S, Zamboni N, Egli A, Niess JH, Hruz P, Knuth A, Fritsch R, Manz MG, Wawrzyniak M, Scharl M

doi: 10.1080/19490976.2025.2530157

Inflammatory Bowel Disease

Differences in the Adverse Event Burden of Corticosteroid Use in Inflammatory Bowel Disease as Reported Between Adverse Event Reporting Systems and a Patient Questionnaire

J Crohns Colitis

Al Sulais E, Louis E, Bokemeyer B, Gecse KB, Parkes GC, Parkes M, Selinger C, Munsaka M, Liu M, Crooks J, Finney-Hayward T, Raine T

doi: 10.1093/ecco-jcc/jjae138

COMMENTED

Esophagus Diseases

Eosinophilic esophagitis patients report substantial disease burden comparable to more systemic immune-mediated diseases

★ 3 Recommended and commented by Prof. Dr Stephan Vavricka, Faculty Member

BMC Gastroenterol

Theswet E, Brücker C, Kreienbühl A, Greuter T, Schoepfer AM, Straumann A, Biedermann L

doi: 10.1186/s12876-025-03942-8

Inflammatory Bowel Disease

Deucravacitinib in Patients With Inflammatory Bowel Disease: 12-Week Efficacy and Safety Results From Three Randomized Phase 2 Studies in Crohn's Disease and Ulcerative Colitis

J Crohns Colitis

D'Haens G, Danese S, Panaccione R, Rubin DT, Peyrin-Biroulet L, Matsuoka K, Loftus EV Jr, Kobayashi T, Elsharkawi W, Miceli R, Ahmed S, Luo Y, Napoli A, Vaile J, Dornic Q, Patel A, Schreiber S

doi: 10.1093/ecco-jcc/jjaf080

RECOMMENDED

Inflammatory Bowel Disease

Incidence, disease burden and clinical presentation of patients newly diagnosed with inflammatory bowel disease in a population-based inception cohort

★ 1 Recommended by Prof. Dr Stephan Vavricka, Faculty Member

J Crohns Colitis

Attauabi M, Madsen GR, Bendtsen F, Seidelin JB, Burisch J

doi: 10.1093/ecco-jcc/jjae176

Inflammatory Bowel Disease

Undetected Dysplasia at Colectomy in Patients With Inflammatory Bowel Diseases. What Are We Missing?

Inflamm Bowel Dis

Centorrino E, Ferrari D, Harmsen WS, Larson DW, Loftus EV Jr, Coelho-Prabhu N

doi: 10.1093/ibd/izae274

Inflammatory Bowel Disease

The Effectiveness of Oral Vancomycin on Inflammatory Bowel Disease in Patients With Primary Sclerosing Cholangitis: A Systematic Review

Inflamm Bowel Dis

Arbabzada N, Dennett L, Meng G, Peerani F

doi: 10.1093/ibd/izae257

Inflammatory Bowel Disease

Food Compounds Associated With Disease Activity in Inflammatory Bowel Disease

Inflamm Bowel Dis

Meima M, Westerhout J, Meijerink M, Bijlsma S, van Schaik F, Oldenburg B, Houben G

doi: 10.1093/ibd/izaf126

RECOMMENDED

Inflammatory Bowel Disease

Radiation exposure in patients with inflammatory bowel disease

★ 1 Recommended by Prof. Dr Stephan Vavricka, Faculty Member

J Crohns Colitis

Jorissen T, Fierens L, Bosmans H, Verstockt B, Sabino J, Vermeire S, Vanbeckevoort D, Ferrante M

doi: 10.1093/ecco-jcc/jjaf001

Related content

Blood-borne immune cells carry low biomass DNA remnants of microbes in patients with colorectal cancer or inflammatory bowel disease

Differences in the Adverse Event Burden of Corticosteroid Use in Inflammatory Bowel Disease as Reported Between Adverse Event Reporting Systems and a Patient Questionnaire

Eosinophilic esophagitis patients report substantial disease burden comparable to more systemic immune-mediated diseases

Deucravacitinib in Patients With Inflammatory Bowel Disease: 12-Week Efficacy and Safety Results From Three Randomized Phase 2 Studies in Crohn's Disease and Ulcerative Colitis

Incidence, disease burden and clinical presentation of patients newly diagnosed with inflammatory bowel disease in a population-based inception cohort

Undetected Dysplasia at Colectomy in Patients With Inflammatory Bowel Diseases. What Are We Missing?

The Effectiveness of Oral Vancomycin on Inflammatory Bowel Disease in Patients With Primary Sclerosing Cholangitis: A Systematic Review

Food Compounds Associated With Disease Activity in Inflammatory Bowel Disease

Radiation exposure in patients with inflammatory bowel disease